Tag Archives: Female Cancers

Gynecological Cancer Mortality Rates for Women Increases

Don't Let Stress Get To You! Take a Deep Breath.
Increasing Cancer Rates in Women

While billions of dollars are spent each year on the fight against cancer, the American Cancer Society projects that the number of female deaths from cancer will reach 5.5 million by 2030. That represents nearly a 60 percent increase from the 3.5 million totals in 2012.

What factors are driving this alarming increase? According to the ACS, where you live can make a big difference.

The Importance of Early Detection

Early detection and treatment greatly improves the odds of surviving cancer, but residents of economically disadvantaged countries don’t have access to high-quality health care. The highest mortality rates are in underprivileged nations such as Zimbabwe, Kenya and Mongolia.

Breast cancer survival rates also follow this pattern. The five-year survival rate tops 85 percent in high-income countries such as Canada and Australia, but the number drops to 60 percent or less in low- and middle-income nations including South Africa and India.

Lifestyles Can Increase Risk of Cancer

In addition, lifestyles vary from country to country, which play a part in the incidence of cancer. For example, women in China develop lung cancer at a higher rate than breast cancer, which is the most commonly diagnosed form in the world. Approximately 50 percent of Chinese men smoke, making second-hand smoke a likely cause of their high lung cancer rate.

Immunotherapy for Cancer: A Vital Weapon in the War against Cancer

At Issels®, we have successfully treated patients with all forms of cancer, including breast and lung. Contact us today to learn more about how immunotherapy for cancer boosts your body’s own natural defenses against the disease.

A Look Back at the Successes in Treating Ovarian Cancer

Prostate Cancer
Treating Ovarian Cancer

For the many drafted into the fight against ovarian cancer, its sub-40% cure rate can seem especially daunting. No matter where you’re at in your cancer journey, Issels® wants you to know you have an increased fighting chance thanks to these ovarian cancer treatment advancements which can stop aggressively growing tumors from endangering vital organs and gain time for immunotherapy to work.

Let’s celebrate our success in the hard-fought battle against ovarian cancer!

  • Changes to surgical principles
    Now that the role of surgery is more clearly understood, complete surgical staging (checking the spread of cancer) and debulking (the removal of cancerous tumors), is now recommended for nearly all patients suspected of harboring any residual disease in order to create better outcomes.
  • Intraperitoneal chemotherapy
    A major development in ovarian cancer treatment, this stage three cancer therapy delivers a concentrated dose of chemotherapy directly to the cancer site via a catheter inserted into the abdominal cavity. Strong evidence now associates its use with a major improvement in median ovarian cancer survival rates in women.
  • The addition of bevacizumab
    Bevacizumab, an angiogenesis inhibitor, has offered ovarian cancer victims a variety of bevacizumab-containing regimens which slow the growth of new blood vessels, offering a progression-free survival as opposed to overall survival when other methods have been exhausted.

Who do we have to thank for these treatments?
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.

Do you have the right cancer battle strategy? Plot your course for a better life with Issels® today.